TAILIEUCHUNG - Global Infectious Disease Surveillance and Detection: Assessing the Challenges— Finding Solutions

The Forum on Emerging Infections was created by the Institute of Medicine (IOM) in 1996 in response to a request from the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). The purpose of the Forum is to provide structured opportunities for leaders from government, academia, and industry to meet and examine issues of shared concern regarding research, prevention, detection, and management of emerging or reemerging infectious diseases. In pursuing this task, the Forum provides a venue to foster the exchange of information and ideas, identify areas in need of greater attention, clarify policy issues. | Forum on Microbial Threats GLOBAL INFECTIOUS DISEASE SURVEILLANCE AND DETECTION Assessing the challenges Finding Solutions Workshop Summary a INSTITUTE cs ME OF THE NAĨTONAL. till II Global Infectious Disease Surveillance and Detection Assessing the Challenges Finding Solutions Workshop Summary Rapporteurs Stanley M. Lemon Margaret A. Hamburg P. Frederick Sparling Eileen R. Choffnes and Alison Mack Forum on Microbial Threats Board on Global Health INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES THE NATIONAL ACADEMIES PRESS Washington . THE NATIONAL ACADEMIES PRESS 500 Fifth Street . Washington DC 20001 NOTICE The project that is the subject of this report was approved by the Governing Board of the National Research Council whose members are drawn from the councils of the National Academy of Sciences the National Academy of Engineering and the Institute of Medicine. This project was supported by contracts between the National Academy of Sciences and the . Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases Centers for Disease Control and Prevention and Food and Drug Administration . Department of Defense Global Emerging Infections Surveillance and Response System Walter Reed Army Institute of Research and Defense Threat Reduction Agency . Department of Veterans Affairs . Department of Homeland Security Lawrence Livermore National Laboratory American Society for Microbiology Sanofi Pasteur Burroughs Wellcome Fund Pfizer GlaxoSmithKline Infectious Diseases Society of America and the Merck Company Foundation. Any opinions findings conclusions or recommendations expressed in this publication are those of the author s and do not necessarily reflect the view of the organizations or agencies that provided support for this project. International Standard Book Number-13 978-0-309-11114-0 International Standard Book Number-10 0-309-11114-5 Additional copies of this report are

• Y học thường thức
• increasingly complex
• human diseases
• biosignatures
• incubation periods
• health care
• health care expenditures
• BMC Genomics
• Gene editing
• Genomic complexity
• Sequencing technology development
• Complex genetics
• BMC Bioinformatics
• Query expansion
• Biomedical information retrieval
• Linear combination
• BMC Geriatrics
• End of life expenditure
• Long term care
• Geriatric care
• Healthcare planning
• Healthcare expenditures
• Health Insurance
• Healthcare utilization
• Poor and near Poor
• Out ofpocket expenditures
• Including healthcare utilization
• BMC Cancer
• Healthcare expenditure
• End of life
• Healthcare disparities
• Cancer patients
• Economic status